The Potential Impact of Watson for Clinical Oncology – Part 1
Chapter 1In this video, Andrew Norden, MD, MPH, MBA, deputy chief health officer at IBM Watson Health in Boston, Massachusetts, discusses how IBM’s Watson program is expected to help recommend treatments for patients with cancer.
Chapter 2
The Potential Impact of Watson for Clinical Oncology – Part 2
In this video, Andrew Norden, MD, MPH, MBA, deputy chief health officer at IBM Watson Health in Boston, Massachusetts, discusses how IBM’s Watson program is expected to help recommend treatments for patients with cancer.
Chapter 3
The Potential Impact of Watson for Clinical Oncology – Part 3
In this video, Andrew Norden, MD, MPH, MBA, deputy chief health officer at IBM Watson Health in Boston, Massachusetts, discusses how IBM’s Watson program is expected to help recommend treatments for patients with cancer.
